Europska Unija - hrvatski - EMA (European Medicines Agency)

pfizer europe ma eeig - parekoksib natrij - bol, postoperativna - coxibs, antiinflammatory and antirheumatic products - za kratkotrajno liječenje postoperativne boli kod odraslih.

Europska Unija - hrvatski - EMA (European Medicines Agency)

pfizer europe ma eeig - anidulafungin - kandidijaza - antimikotika za sustavnu uporabu - liječenje od invazivnog kandidijaze kod odraslih i pedijatrijska bolesnika u dobi od 1 mjeseca do < 18 godina.

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

reckitt benckiser d.o.o., ulica grada vukovara 269d, zagreb, hrvatska - flurbiprofen - pastila - urbroj: jedna pastila sadrži 8,75 mg flurbiprofena.

Europska Unija - hrvatski - EMA (European Medicines Agency)

axunio pharma gmbh - pirfenidone - idiopatska plućna fibroza - imunosupresivi - pirfenidone aet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Europska Unija - hrvatski - EMA (European Medicines Agency)

zoetis belgium sa - mcloksikam - oxicams - psi - olakšanje upala i bolova u akutni i kronični mišićno-koštanog sustava u pasa.

Europska Unija - hrvatski - EMA (European Medicines Agency)

sanofi winthrop industrie - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - antitrombotska sredstva - duoplavin je indiciran za sekundarnu prevenciju aterotrombotskih događaja u bolesnika odraslih koji već uzimaju i klopidogrel i acetilsalicilnu kiselinu (asa). duoplavin is a fixed-dose combination medicinal product for continuation of therapy in:non st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary intervention (pci);st segment elevation acute myocardial infarction (stemi) in patients undergoing a stent placement) or medically treated patients eligible for thrombolytic/fibrinolytic therapy. za više informacija, molimo pogledajte odjeljak 5.

Europska Unija - hrvatski - EMA (European Medicines Agency)

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - dijabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

medicina promet d.o.o., zagreb - injekcijske štrcaljke sa i bez igli i injekcijske igle

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

medicina promet d.o.o., zagreb - trake za analizu urina

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

medicina promet d.o.o., zagreb - dezinficijensi